Gregory Wilding, PhD (Series Introduction) Professor Department of Biostatistics School of Public Health and Health Professions Director, CTSI BERD Core Michael LaMonte, PhD, MPH (Clinical Trials ...

Many clinical trials include a placebo group—participants who receive an inactive treatment—so researchers can compare ...

Many people are surprised to learn that clinical trials aren't just for people who have run out of standard treatment options ...

With populations aging, chronic diseases becoming more prevalent, and global health experts warning of potential pandemics, the need for rapid therapeutic development has reached unprecedented levels.

This workshop reviews the basics of Good Clinical Practice (GCP) and the recent updates that impact practice in an increasingly electronic environment. It will highlight the responsibilities the ...

Carrie Madormo, RN, MPH, is a health writer. She has over a decade of experience as a registered nurse, practicing in a variety of fields, such as pediatrics, oncology, chronic pain, and public health ...

In a time when COAs are more nuanced, critical and complex than ever, researchers can turn to best practices to move forward ...

A major international congress for the global pharmacology and therapeutics community, spanning both basic and clinical ...

The future of clinical research depends on people just as much as strong systems and processes. Learn what makes great ...

What Are Clinical Trials for MASH? Clinical trials for MASH are research studies that evaluate potential new treatments for a form of liver disease called metabolic dysfunction-associated ...